Estimating the prevalence and incidence of type 2 diabetes using population level pharmacy claims data: a cross-sectional study

Show simple item record

dc.contributor.author Sinnott, Sarah-Jo
dc.contributor.author McHugh, Sheena M.
dc.contributor.author Whelton, Helen
dc.contributor.author Layte, Richard
dc.contributor.author Barron, Steve J.
dc.contributor.author Kearney, Patricia M.
dc.date.accessioned 2017-01-18T09:44:13Z
dc.date.available 2017-01-18T09:44:13Z
dc.date.issued 2017-01-01
dc.identifier.citation Sinnott, S.-J., McHugh, S., Whelton, H., Layte, R., Barron, S. and Kearney, P. M. (2017) 'Estimating the prevalence and incidence of type 2 diabetes using population level pharmacy claims data: a cross-sectional study', BMJ Open Diabetes Research & Care, 5(1). doi:10.1136/bmjdrc-2016-000288 en
dc.identifier.volume 5 en
dc.identifier.issued 1 en
dc.identifier.startpage e000288-1 en
dc.identifier.endpage e000288-5 en
dc.identifier.issn 2052-4897
dc.identifier.uri http://hdl.handle.net/10468/3476
dc.identifier.doi 10.1136/bmjdrc-2016-000288
dc.description.abstract Objective: To estimate the prevalence and incidence of type 2 diabetes using a national pharmacy claims database. Research design and methods We used data from the Health Service Executive-Primary Care Reimbursement Service database in Ireland for this cross-sectional study. Prevalent cases of type 2 diabetes were individuals using an oral hypoglycemic agent, irrespective of insulin use, in 2012. Incident cases were individuals using an oral hypoglycemic agent in 2012 who had not used one in the past. Population level estimates were calculated and stratified by age and sex. Results: In 2012, there were 114 957 prevalent cases of type 2 diabetes giving a population prevalence of 2.51% (95% CI 2.49% to 2.52%). Among adults (≥15yrs), this was 3.16% (95% CI 3.15% to 3.18%). The highest prevalence was in those aged 70+ years (12.1%). 21 574 people developed type 2 diabetes in 2012 giving an overall incidence of 0.48% (95% CI 0.48% to 0.49%). In adults, this was 0.60% (95% CI 0.60% to 0.61%). Incidence rose with age to a maximum of 2.08% (95% CI 2.02% to 2.15%) in people aged 65–69 years. Men had a higher prevalence (2.96% vs 2.04%) and incidence (0.54% vs 0.41%) of type 2 diabetes than women. Conclusions: Pharmacy claims data allow estimates of objectively defined type 2 diabetes at the population level using up-to-date data. These estimates can be generated quickly to inform health service planning or to evaluate the impact of population level interventions. en
dc.description.sponsorship Health Research Board, Ireland ((HRB grant no. PHD/2007/16), (Health Research Board Leadership Award in Diabetes (RL/2013/7)); Centre for Ageing and Development Research in Ireland (CARDI Leadership Fellowship) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher BMJ Publishing Group en
dc.rights © 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ en
dc.rights.uri http://creativecommons.org/licenses/by-nc/4.0/ en
dc.subject Type 2 diabetes en
dc.subject Health service planning en
dc.subject Population level interventions en
dc.subject Public Health en
dc.subject Ireland en
dc.subject Diabetes en
dc.title Estimating the prevalence and incidence of type 2 diabetes using population level pharmacy claims data: a cross-sectional study en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Patricia Kearney, Epidemiology & Public Health, University College Cork, Cork, Ireland. +353-21-490-3000 Email: patricia.kearney@ucc.ie en
dc.internal.availability Full text available en
dc.date.updated 2017-01-18T09:27:21Z
dc.description.version Published Version en
dc.internal.rssid 380109623
dc.contributor.funder Health Research Board en
dc.contributor.funder Centre for Ageing Research and Development in Ireland en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Bmj Open Diabetes Research & Care en
dc.internal.copyrightchecked No !!CORA!! en
dc.internal.licenseacceptance Yes en
dc.internal.IRISemailaddress patricia.kearney@ucc.ie en


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Except where otherwise noted, this item's license is described as © 2017 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement